Quick Answer
MANGOCEUTICALS, INC. reported Stockholders Equity of $13.95 million for fiscal year 2024.
MANGOCEUTICALS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | $13.95M | +1700.1% |
| 2023 | $774.8K | +26.2% |
| 2022 | $614.0K | +3772.4% |
| 2021 | -$16.7K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $15.73M | +17.5% | -18.3% |
| June 30, 2025 | $19.24M | +39.1% | -5.0% |
| March 31, 2025 | $20.25M | +2213.0% | +45.2% |
| December 31, 2024 | $13.95M | +1700.1% | +4.2% |
| September 30, 2024 | $13.39M | +888.3% | -3.2% |
| June 30, 2024 | $13.83M | +360.6% | +1543.0% |
| March 31, 2024 | -$958.4K | -125.1% | -223.7% |
| December 31, 2023 | $774.8K | +26.2% | -42.8% |
- MANGOCEUTICALS, INC. showed an increase of +1700.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2021–2024 period, MANGOCEUTICALS, INC.’s stockholders equity has grown by 83509.9% (from -$16.7 thousand to $13.95 million).
- The most recent figure is from MANGOCEUTICALS, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 20, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: